eMedicine Specialties > Emergency Medicine > Endocrine & Metabolic
Syndrome of Inappropriate Antidiuretic Hormone Secretion: Follow-up
Updated: Oct 20, 2009
Follow-up
Further Inpatient Care
- Inpatient care is indicated for severe symptomatic hyponatremia or for treatment of the underlying disease.
Further Outpatient Care
- Water restriction is the mainstay of treatment. Patients with sodium levels of more than 125 mEq/L can be managed with water restriction of 500 mL per day and close follow-up.
- For refractory cases of SIADH, consider pharmacologic therapy.
Inpatient & Outpatient Medications
- See Medications.
Complications
- Central pontine myelinolysis (CPM) is the most feared complication of excessive, overly rapid correction of hyponatremia. Typical features are disorders of upper motor neurons including spastic quadriparesis and pseudobulbar palsy, and mental disorders ranging from confusion to coma.20 The risk is increased in persons with hepatic failure, potassium depletion, large burns, and malnutrition.13 Once central pontine myelinolysis occurs as a complication, there is no proven treatment.
- Patients with cerebral disease or underlying metabolic disorders (eg, alcoholism, liver disease, malnutrition, hypokalemia, large burns) are at increased risk for CPM. Premenopausal patients undergoing surgery, especially gynecologic or related procedures, may also have an increased risk.
- CPM is more likely in patients with long-standing, severe hyponatremia that is corrected too rapidly.
- Risk is minimal if hyponatremia develops over less than 48 hours, even with rapid correction.
- Onset of CPM may be delayed, manifesting days after correction, despite initial clinical improvement.
Prognosis
- The prognosis of SIADH best correlates to the underlying cause.
- Rapid and complete recovery tends to be the rule for recovery from drug-induced SIADH when the offending agent is withdrawn.
- Successful treatment of pulmonary or CNS infection can lead to correction of SIADH.
- Patients who present with neurologic symptoms, cerebral edema, or severe hyponatremia may develop permanent neurologic impairment.
Patient Education
- Emphasize the importance of compliance with fluid restriction.
- Patients must understand that a typical diet may contain 750-1000 mL of water before accounting for free water intake.
- Voluntary fluid intake may have to be limited to 250-500 mL (ie, 1-2 glasses) per day.
Miscellaneous
Medicolegal Pitfalls
- Correcting hyponatremia too rapidly may result in CPM with permanent neurologic deficits.
- Given the strong association with small cell carcinoma of the lung, aggressive workup for occult small cell carcinoma in patients without an alternative explanation for their SIADH may be warranted.
- Attributing low sodium to laboratory error is a pitfall.
The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors, Alexandr Rafailov, MD, Richard H Sinert, DO, and James Foster, MD, to the development and writing of this article.
More on Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Overview: Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Differential Diagnoses & Workup: Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Treatment & Medication: Syndrome of Inappropriate Antidiuretic Hormone Secretion |
Follow-up: Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| References |
| « Previous Page |
References
Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. May 10 2008;371(9624):1624-32. [Medline].
Verbalis JG, Berl T. Disorders of water balance. In: Brenner BM. Brenner & Rector's The Kidney. Vol 1. 8th ed. Saunders; 2007:459-491.
Leaf A, Mamby AR. An antidiuretic mechanism not regulated by extracellular fluid tonicity. J Clin Invest. Jan 1952;31(1):60-71. [Medline].
Rai A, Whaley-Connell A, McFarlane S, Sowers JR. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism. Am J Nephrol. 2006;26(6):579-89. [Medline].
Decker BC. Disorders of Water Excess: Hyponatremia. In: Dale DC, Federman DD, eds. ACP Medicine. Vol 1. BC Decker; 2007.
Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. Jan 2006;21(1):70-6. [Medline].
Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. Jul 2006;17(7):1820-32. [Medline].
Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care. 2008;12(6):R162. [Medline].
Hsu YJ, Chiu JS, Lu KC, Chau T, Lin SH. Biochemical and etiological characteristics of acute hyponatremia in the emergency department. J Emerg Med. Nov 2005;29(4):369-74. [Medline].
Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. Jan 2006;119(1):71.e1-8. [Medline].
Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. Jul 2006;119(7 Suppl 1):S30-5. [Medline].
Chua M, Hoyle GE, Soiza RL. Prognostic implications of hyponatremia in elderly hospitalized patients. Arch Gerontol Geriatr. Nov-Dec 2007;45(3):253-8. [Medline].
Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. May 25 2000;342(21):1581-9. [Medline].
Kohen I, Voelker S, Manu P. Antipsychotic-induced hyponatremia: case report and literature review. Am J Ther. Sep-Oct 2008;15(5):492-4. [Medline].
Agrawal NK, Rastogi A, Goyal R, Singh SK. Sertraline-induced hyponatremia in the elderly. CJEM. Nov 2007;9(6):415. [Medline].
Morris JE. Fluid, Electrolyte, & Acid-Base Emergencies. In: Stone CK, Humphries RL, eds. Current Diagnosis & Treatment: Emergency Medicine. 6th ed. McGraw-Hill Professional; 2007:814-818.
Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. Nov 2007;2(6):1110-7. [Medline].
[Best Evidence] Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. Nov 16 2006;355(20):2099-112. [Medline].
Gross P. Treatment of hyponatremia. Intern Med. 2008;47(10):885-91. [Medline].
Kumar S, Fowler M, Gonzalez-Toledo E, Jaffe SL. Central pontine myelinolysis, an update. Neurol Res. Apr 2006;28(3):360-6. [Medline].
Further Reading
Keywords
SIADH, antidiuretic hormone, ADH, vasopressin, syndrome of inappropriate antidiuretic hormone secretion, hyponatremia, elevated urine osmolality, excessive sodium excretion, renal excretion of water, concentrated urine, ADH dysregulation, exercise-induced hyponatremia, osmolarity, cerebral salt wasting, reset osmostat
Follow-up: Syndrome of Inappropriate Antidiuretic Hormone Secretion